News
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $47.66, moving +1.88% from the previous trading session.
A recent discovery could transform our understanding of bone health maintenance and pave the way for potential treatments for ...
Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making ...
Using a modified CRISPR-based mechanism, the team led by Prof. Pallob Kundu has developed a stress-activated gene switch that empowers plants to survive extreme heat and microbial attacks.
Researchers at Shanghai Jiao Tong University have produced fertile adult mice from embryos constructed entirely with male ...
CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.
Innovation in biotechnology has reached new heights with the advancement of microbial genome editing services. These services enable researchers and industries to modify the genetic makeup of ...
Scientists achieved a breakthrough. They bred healthy, fertile mice using DNA from two sperm cells. This was done through ...
Researchers used epigenome engineering and CRISPR to reprogram sperm DNA, allowing embryos to develop with only fathers.
Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with ...
US health secretary Robert F Kennedy Jr has pledged to cut red tape and maintain the country's biotech leadership, in spite ...
A smart molecular tool developed by scientists can aid plants facing rising temperatures and infections.Plants often feel stressed, especially when the weather is extreme or microbes attack. When they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results